NNPA NEWSWIRE — The most exciting news is that the National Institute of Health’s is making progress on genetic therapies for SCD that are potentially curative. While these treatments are not available to everyone, there is real promise that more accessible genetic cures could give people living with SCD the pain-free lives they deserve. With the Food and Drug Administration accelerated approvals of two new SCD drugs, it is an encouraging momentum for more life-saving new medicines on the horizon.